BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16292092)

  • 1. Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: results of a randomized clinical trial.
    Wenger U; Johnsson E; Bergquist H; Nyman J; Ejnell H; Lagergren J; Ruth M; Lundell L
    Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1369-77. PubMed ID: 16292092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial.
    Bergquist H; Wenger U; Johnsson E; Nyman J; Ejnell H; Hammerlid E; Lundell L; Ruth M
    Dis Esophagus; 2005; 18(3):131-9. PubMed ID: 16045572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial.
    Adamson D; Blazeby J; Nelson A; Hurt C; Nixon L; Fitzgibbon J; Crosby T; Staffurth J; Evans M; Kelly NH; Cohen D; Griffiths G; Byrne A
    Trials; 2014 Oct; 15():402. PubMed ID: 25336193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial.
    Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
    Lancet; 2004 Oct 23-29; 364(9444):1497-504. PubMed ID: 15500894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer.
    Polinder S; Homs MY; Siersema PD; Steyerberg EW;
    Br J Cancer; 2004 Jun; 90(11):2067-72. PubMed ID: 15150566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in palliative therapy.
    Siersema PD
    Best Pract Res Clin Gastroenterol; 2006; 20(5):959-78. PubMed ID: 16997172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study].
    Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
    Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2800-6. PubMed ID: 16385833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy.
    Nicholson DA; Haycox A; Kay CL; Rate A; Attwood S; Bancewicz J
    Clin Radiol; 1999 Apr; 54(4):212-5. PubMed ID: 10210338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer.
    Touchefeu Y; Archambeaud I; Landi B; Lièvre A; Lepère C; Rougier P; Mitry E
    Dig Liver Dis; 2014 Mar; 46(3):283-6. PubMed ID: 24268567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma.
    Sabharwal T; Hamady MS; Chui S; Atkinson S; Mason R; Adam A
    Gut; 2003 Jul; 52(7):922-6. PubMed ID: 12801944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative therapy.
    Homs MY; Kuipers EJ; Siersema PD
    J Surg Oncol; 2005 Dec; 92(3):246-56. PubMed ID: 16299791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer--results of a prospective safety study.
    Bergquist H; Johnsson E; Nyman J; Rylander H; Hammerlid E; Friesland S; Ejnell H; Lundell L; Ruth M
    Dis Esophagus; 2012 Jul; 25(5):410-5. PubMed ID: 21899654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptable results after self-expanding metallic stent treatment for dysphagia in non-resectable oesophageal cancer.
    Bjerring OS; Pless T; Fristrup C; Mortensen MB
    Dan Med J; 2012 Jun; 59(6):A4459. PubMed ID: 22677249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer.
    Hirdes MM; van Hooft JE; Wijrdeman HK; Hulshof MC; Fockens P; Reerink O; van Oijen MG; van der Tweel I; Vleggaar FP; Siersema PD
    Gastrointest Endosc; 2012 Aug; 76(2):267-74. PubMed ID: 22695208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative treatment of oesophageal carcinoma--efficacy of plastic versus self-expandable stents.
    Sanyika C; Corr P; Haffejee A
    S Afr Med J; 1999 Jun; 89(6):640-3. PubMed ID: 10443214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy.
    Homs MY; Essink-Bot ML; Borsboom GJ; Steyerberg EW; Siersema PD;
    Eur J Cancer; 2004 Aug; 40(12):1862-71. PubMed ID: 15288288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for dysphagia in oesophageal cancer.
    Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005048. PubMed ID: 19821338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic analysis of esophageal stenting for management of malignant dysphagia.
    Rao C; Haycock A; Zacharakis E; Krasopoulos G; Yakoub D; Protopapas A; Darzi A; Hanna GB; Athanasiou T
    Dis Esophagus; 2009; 22(4):337-47. PubMed ID: 19207559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection.
    Steyerberg EW; Homs MY; Stokvis A; Essink-Bot ML; Siersema PD;
    Gastrointest Endosc; 2005 Sep; 62(3):333-40. PubMed ID: 16111947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inoperable adenocarcinoma of the oesophagogastric junction: a comparative clinical study of laser coagulation versus self-expanding metallic stents with special reference to cost analysis.
    Sihvo EI; Pentikäinen T; Luostarinen ME; Rämö OJ; Salo JA
    Eur J Surg Oncol; 2002 Nov; 28(7):711-5. PubMed ID: 12431467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.